Connect with us

Health & Fitness

Lilly Stops Antibody Trial in Hospitalized COVID-19 Patients

The company cited new data from the NIH showing no significant benefit for bamlanivimab in combination with remdesivir for people hospitalized with COVID-19. Medscape Medical News

Published

on

Lilly Stops Antibody Trial in Hospitalized COVID-19 Patients

The company cited new data from the NIH showing no significant benefit for bamlanivimab in combination with remdesivir for people hospitalized with COVID-19. Medscape Medical News
Read More